AZ’s Ticagrelor, BI’s Triple Combo to Take Another Stab to Clear MHLW Committee

AstraZeneca’s oral antiplatelet agent ticagrelor and Nippon Boehringer Ingelheim’s triple combo hypertension drug will come up for discussion at a key health ministry panel on September 7 in their second and third attempts to clinch their recommendation for approval. At...read more